Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells

Sung Ho Kim, Hyo Soon Yoo, Moon Kyung Joo, Taehyun Kim, Jong Jae Park, Beom Jae Lee, Hoon Jai Chun, Sang Woo Lee, Young Tae Bak

    Research output: Contribution to journalArticlepeer-review

    24 Citations (Scopus)


    Background: We investigated the effect of arsenic trioxide (ATO) for inhibition of signal transducer and activator of transcription 3 (STAT3) and epithelial-mesenchymal transition (EMT) in gastric cancer cells, and the role of SH2 domain-containing phosphatase-1 (SHP-1) during this process. Methods: We used AGS cells, which showed minimal SHP-1 expression and constitutive STAT3 expression. After treatment of ATO, cellular migration and invasion were assessed by using wound closure assay, Matrigel invasion assay and 3-D culture invasion assay. To validate the role of SHP-1, pervanadate, a pharmacologic phosphatase inhibitor, and SHP-1 siRNA were used. Xenograft tumors were produced, and ATO or pervanadate were administered via intraperitoneal (IP) route. Results: Treatment of ATO 5 and 10 μM significantly decreased cellular migration and invasion in a dose-dependent manner. Western blot showed that ATO upregulated SHP-1 expression and downregulated STAT3 expression, and immunofluorescence showed upregulation with E-cadherin (epithelial marker) and downregulation of Snail1 (mesenchymal marker) expression by ATO treatment. Anti-migration and invasion effect and modulation of SHP-1/STAT3 axis by ATO were attenuated by pervanadate or SHP-1 siRNA. IP injection of ATO significantly decreased the xenograft tumor volume and upregulated SHP-1 expression, which were attenuated by co-IP injection of pervanadate. Conclusion: Our data suggest that ATO inhibits STAT3 activity and EMT process by upregulation of SHP-1 in gastric cancer cells.

    Original languageEnglish
    Article number150
    JournalBMC Cancer
    Issue number1
    Publication statusPublished - 2018 Feb 6

    Bibliographical note

    Funding Information:
    This study was financially supported by Korea University Grant (Grant number: K1512661, for the design of the study and collection, analysis, and interpretation of data) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: NRF-2016R1D1A1A02936964, for the design of the study and collection).

    Publisher Copyright:
    © 2018 The Author(s).


    • Arsenic trioxide
    • Epithelial-mesenchymal transition
    • SH2-containing protein tyrosine phosphatase 1
    • Signal transducer and activator of transcription 3

    ASJC Scopus subject areas

    • Oncology
    • Genetics
    • Cancer Research


    Dive into the research topics of 'Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells'. Together they form a unique fingerprint.

    Cite this